Core Viewpoint - The company focuses on products primarily used for landscaping maintenance, including various types of lawn mowers and robotic lawn mowers [1] Group 1 - The company's products are mainly applied in landscaping and maintenance [1] - Key products related to lawns include push lawn mowers, riding lawn mowers, and automatic lawn mowing robots [1]

根据调研日期截止日统计，近10日（5月20日至6月3日），海外机构对81家上市公司进行调研，其中， 奥普特最受关注，被29家海外机构密集调研。 证券时报·数据宝统计显示，近10日共有574家公司获机构调研，调研机构类型显示，证券公司调研达 516家，占比最多；基金公司调研430家，位列其后；海外机构共对81家上市公司进行走访。 海外机构调研榜单中，奥普特参与调研的海外机构达到29家，最受关注；其次是澜起科技，参与调研的 海外机构共有27家。 从股价表现看，获海外机构调研股近10日平均上涨2.72%。其中，股价上涨的有益方生物、潮宏基等， 表现最好的是益方生物，累计涨幅为56.53%。股价下跌的有37只，跌幅最大的是中坚科技，累计跌幅 为22.90%。（数据宝） 近10日海外机构调研股 | 证券代码 | 证券简称 | 海外机构家数 | 最新收盘价（元） | 其间涨跌幅（%） | 行业 | | --- | --- | --- | --- | --- | --- | | 688382 | 益方生物 | 1 | 31.76 | 56.53 | 医药生物 | | 002345 | 潮宏基 | 2 | 15.81 | 5 ...

证券代码：002779 证券简称：中坚科技 公告编号：2025-027 浙江中坚科技股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江中坚科技股份有限公司（以下简称"公司"）2024 年年度权益分派 方案已获 2025 年 5 月 22 日召开的 2024 年年度股东大会审议通过，现将权益 分派事宜公告如下： 一、股东大会审议通过利润分配及资本公积金转增股本方案的情况 1、2025 年 5 月 22 日，公司召开 2024 年年度股东大会审议通过了《关于 2024 年度利润分配及资本公积金转增股本预案的议案》。具体方案如下：以公司总股 本 132,000,000 股为基数，向全体股东每 10 股派发现金红利 1.1 元（含税），合 计派发现金红利为 14,520,000 元（含税）；不送红股；以资本公积金向全体股东 每 10 股转增 4 股，转增后，公司总股本增加至 184,800,000 股（具体股数以实施 完毕后中国证券登记结算有限责任公司深圳分公司确认的股数为准）。 2、公司利润分配及资本公积转增方案披露 ...

Group 1 - The core viewpoint of the article highlights that Zhongan Technology is increasing its investment in the smart robotics sector, projecting a revenue of 971 million yuan in 2024, which represents a year-on-year growth of 45.64% [1] - The company anticipates a net profit attributable to the parent company of 64.67 million yuan in 2024, reflecting a year-on-year increase of 34.47% [1] - For the first quarter of 2025, Zhongan Technology expects to achieve a revenue of 286 million yuan, marking a year-on-year growth of 4.96%, with a net profit of 42.21 million yuan, up 36.13% year-on-year [1] Group 2 - The company plans to significantly increase its R&D investment to 72.68 million yuan in 2024, which is a substantial year-on-year increase of 137.5%, with nearly 15% of its workforce dedicated to R&D [1] - Zhongan Technology's business segments in embodied intelligence have begun to form a collaborative structure with three main areas: robot components, quadruped robots, and health care robots, facilitating the transition of products towards intelligence and automation [1] - The company aims to transform from traditional landscaping machinery to advanced intelligent manufacturing, focusing on the robotics sector and building an outdoor landscaping robot platform to create a comprehensive ecosystem for smart robotics [1]

证券代码：002779 证券简称：中坚科技 公告编号：2025-026 浙江中坚科技股份有限公司 关于持股5%以上股东减持计划期限届满公告 公司持股5%以上股东林高潮保证向公司提供的信息披露内容真实、准确 和完整，没有虚假记载、误导性陈述或重大遗漏。 公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 近日，公司收到林高潮先生出具的《关于股份减持计划期限届满的告知函》， 截至本公告披露日，本次减持计划期限已届满。根据《上市公司股东减持股份管理 暂行办法》《深圳证券交易所上市公司自律监管指引第18号--股东及董事、高级管理 人员减持股份》等相关规定，现将实施情况公告如下： 一、股东减持情况 1、股东减持股份情况 浙江中坚科技股份有限公司（以下简称"公司"或"本公司"）于2025年1月25 日在巨潮资讯网（www.cninfo.com.cn）及《证券时报》披露了《关于持股5%以上股 东减持股份的预披露公告》（公告编号：2025-005）。持有公司 5%以上股份的股东 林高潮计划在公告披露之日起15个交易日之后的 3个月内（即2025年2月25日至 2025年5月24日）以集中竞价和大宗交易方式减持本 ...

Group 1: Investor Relations Activities - The company conducted an investor relations activity on May 23, 2025, in Shanghai, with key personnel including the Vice President and Chief Strategy Officer, Bao Jialong, and the Vice President and Board Secretary, Dai Yongbin [2] - The activity included a risk warning regarding the uncertainties in the artificial intelligence robotics sector, emphasizing the potential impact of industry trends and management expertise on business performance [2] Group 2: Financial Performance - In 2024, the company achieved a revenue of CNY 971 million, representing a year-on-year growth of 45.64% [3] - The net profit attributable to the parent company for 2024 was CNY 34.47 million, with a significant year-on-year increase of 6466.96% [3] - For Q1 2025, the company reported a revenue of CNY 286 million, marking a 4.96% increase year-on-year, and a net profit of CNY 42.21 million, up by 36.13% [3] Group 3: Investment in R&D - The company increased its R&D investment to CNY 72.68 million in 2024, a substantial rise of 137.5% compared to the previous year, with R&D personnel accounting for nearly 15% of the workforce [3] - The focus of R&D efforts includes lithium battery technology and intelligent robotics, contributing to the company's transition towards smart and unmanned production [3] Group 4: Strategic Direction - The company is transitioning from traditional landscaping machinery to advanced intelligent manufacturing, focusing on building an outdoor landscaping robotics platform [4] - The strategic plan for 2025 includes enhancing core business quality, optimizing product structure, and accelerating the commercialization of robotics [4] - The company aims to establish a comprehensive cooperation system with industry partners to achieve mutual benefits across market entities [4]

Core Insights - Zhongjian Technology is focusing on technological innovation and transitioning from traditional landscaping machinery to advanced intelligent manufacturing, aiming to build a complete ecosystem for intelligent robots [1] - The company plans to enhance its main business, explore new breakthroughs, and expand overseas by optimizing its product structure and accelerating smart factory construction [2] Company Strategy - Zhongjian Technology's strategy includes "quality improvement of main business, breakthroughs in emerging areas, and overseas expansion" for 2025 [2] - The company is committed to promoting the commercialization of robots and deepening collaborations with companies like 1X and Huawei [2] Industry Trends - The investor reception day featured discussions on the trends in the humanoid robot industry, including frameworks and investment models, as well as the outlook for China's capital market [1] - Over 80 institutional investors attended the event, showcasing interest in the outdoor landscaping robot platform and the overall intelligent robot ecosystem [2]

德恒上海律师事务所 关于浙江中坚科技股份有限公司 2024 年年度股东大会的 德恒上海律师事务所 关于浙江中坚科技股份有限公司 2024 年年度股东大会的 法律意见 德恒 SHG20160035-00032 号 法律意见 上海市东大名路 501 号上海白玉兰广场办公楼 23 层 电话：021-55989888 传真：021-55989898 邮编：200080 德恒上海律师事务所 关于浙江中坚科技股份有限公司 2024 年年度股东大会的法律意见 致：浙江中坚科技股份有限公司 德恒上海律师事务所接受浙江中坚科技股份有限公司（以下简称"公司"） 委托，指派律师（以下简称"本所律师"）列席公司 2024 年年度股东大会（以 下简称"本次股东大会"），对本次股东大会的合法性进行见证并出具本法律意 见。 本法律意见根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东大会 规则》（以下简称"《股东大会规则》"）等有关法律、法规和规范性文件以及 《浙江中坚科技股份有限公司章程》（以下简称"《公司章程》"）、《浙江中 坚科技股份有限公司股东大会议事规则》 ...

证券代码：002779 证券简称：中坚科技 公告编号：2025-025 浙江中坚科技股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无否决提案的情形。 2、本次股东大会未涉及变更以往股东大会已通过的决议。 1 （一）会议召开情况 1、召开时间： 现场会议召开时间：2025年5月22日（星期四）14:00。 网络投票时间：2025年5月22日（股东大会召开当日）。其中，通过深圳证 券交易所交易系统进行网络投票的具体时间为2025年5月22日（星期四）上午 9:15-9:25，9:30 -11:30，13:00-15:00；通过深圳证券交易所互联网投票系统开始 投票的时间为2025年5月22日（星期四）9:15至15:00期间的任意时间。 2、现场会议召开地点：浙江省永康市经济开发区名园北大道155号公司二楼 会议室。 3、会议方式：本次股东大会采取现场投票和网络投票相结合的方式。 4、召集人：公司董事会。 5、会议主持人：董事长 吴明根先生。 6、本次股东大会的召集、召开与表决程序符合《 ...

Core Viewpoint - The focus of embodied intelligence is shifting towards the healthcare and wellness sector, with leading companies increasing their investments in this area to address the urgent care needs of an aging society [1] Group 1: Industry Trends - Current exploration of embodied intelligence primarily targets industrial scenarios, while fewer companies are focusing on home and healthcare scenarios [1] - Leading companies in the sector, such as Madi Technology, Chuangyao Technology, and Zhongjian Technology, are collaborating with the Shanghai Robotics Industry Technology Research Institute to establish a collaborative development mechanism for healthcare scenarios [1] Group 2: Market Opportunities - Companies like Fourier and Zhiyuan Robotics are also increasing their focus on the healthcare sector, indicating a growing recognition of the potential for embodied intelligence in this market [1] - The industry anticipates that embodied intelligence will play a significant role in the healthcare industry, particularly in response to the pressing care demands of an aging population [1] Group 3: Collaborative Efforts - The successful implementation of embodied intelligence in healthcare will require collaboration among government, enterprises, and elderly care institutions to create an interactive and empathetic robotic care environment [1]